1-9 of 9
Maurizio Burattini
Close
Sort by
Journal Articles

Assessment of Frailty Measures and Their Effect on Survival in a Population of Patients Registered At Marche Region Multiple Myeloma (MM) Registry

Massimo Offidani, MD, Claudia Polloni, Laura Corvatta, Riccardo Centurioni, MD, Giuseppe Visani, Marino Brunori, Silvia Gentili, Massimo Catarini, Arduino Samori, Nicola Blasi, Francesco Alesiani, Patrizia Caraffa, Maurizio Burattini, Piero Galieni, Paolo Fraticelli, Mario Ferranti, Luciano Giuliodori, Pietro Leoni
Journal: Blood
Blood (2011) 118 (21): 2873.
https://doi.org/10.1182/blood.V118.21.2873.2873
Published: 2011
Journal Articles

Infection Complications in Patients with Multiple Myeloma Treated with New-Drug Combinations Including Thalidomide.

Massimo Offidani, Agnese Savini, Laura Corvatta, Claudia Polloni, Silvia Gentili, Annamaria Brioni, Giuseppe Visani, Piero Galieni, Francesco Alesiani, Marino Brunori, Massimo Catarini, Anna Mele, Maurizio Burattini, Arduino Samori, Riccardo Centurioni, Nicola Blasi, Mario Ferranti, Paolo Fraticelli, Rita Rizzi, Pietro Leoni
Journal: Blood
Blood (2009) 114 (22): 2828.
https://doi.org/10.1182/blood.V114.22.2828.2828
Published: 2009
Journal Articles

ThaDD Regimen for Patients with Multiple Myeloma Aged ≥ 65 Years: An Update of the First 50 Patients Enrolled

Massimo Offidani, Laura Corvatta, Claudia Polloni, Maria-Novella Piersantelli, Silvia Gentili, Piero Galieni, Giuseppe Visani, Francesco Alesiani, Massimo Catarini, Marino Brunori, Arduino Samori, Maurizio Burattini, Riccardo Centurioni, Mario Ferranti, Luciano Giuliodori, Marco Candela, Anna Mele, Monica Marconi, Attilio Olivieri, Pietro Leoni
Journal: Blood
Blood (2008) 112 (11): 5186.
https://doi.org/10.1182/blood.V112.11.5186.5186
Published: 2008
Journal Articles

Role of Previous Thalidomide Administration on Final Outcome for 72 Patients with Relapsed Multiple Myeloma (MM) Treated with Bortezomib–Based Therapy

Massimo Offidani, MD, Laura Corvatta, Claudia Polloni, Maria-Novella Piersantelli, Silvia Gentili, Miriana Ruggieri, Lara Malerba, Francesco Alesiani, Massimo Catarini, Marino Brunori, Arduino Samori, Maurizio Burattini, Luisa Minnucci, Anna Mele, Monica Marconi, Pietro Leoni
Journal: Blood
Blood (2008) 112 (11): 5191.
https://doi.org/10.1182/blood.V112.11.5191.5191
Published: 2008
Journal Articles

Safety and Efficacy of ThaDD Regimen in Very Elderly Patients with Multiple Myeloma (MM)

Massimo Offidani, MD, Laura Corvatta, Maria-Novella Piersantelli, Claudia Polloni, Silvia Gentili, Piero Galieni, Giuseppe Visani, Francesco Alesiani, Massimo Catarini, Marino Brunori, Arduino Samori, Maurizio Burattini, Riccardo Centurioni, Mario Ferranti, Luciano Giuliodori, Marco Candela, Monica Marconi, Anna Mele, Pietro Leoni
Journal: Blood
Blood (2008) 112 (11): 5196.
https://doi.org/10.1182/blood.V112.11.5196.5196
Published: 2008
Journal Articles

Thalidomide-Dexamethasone vs Interferon-α-Dexamethasone as Maintenance Treatment after ThaDD Induction for Multiple Myeloma (MM): Final Analysis of a Prospective, Randomized Study.

Massimo Offidani, MD, Claudia Polloni, MD, Laura Corvatta, MD, Maria-Novella Piersantelli, MD, Piero Galieni, MD, Giuseppe Visani, MD, Francesco Alesiani, MD, Massimo Catarini, MD, Marino Brunori, MD, Maurizio Burattini, MD, Riccardo Centurioni, MD, Mario Ferranti, MD, Luciano Giuliodori, MD, Marco Candela, MD, Anna Mele, MD, Monica Marconi, MD, Pietro Leoni, PhD
Journal: Blood
Blood (2007) 110 (11): 532.
https://doi.org/10.1182/blood.V110.11.532.532
Published: 2007
Journal Articles

Thalidomide-Dexamethasone (Thal-dex) vs Interferon-α-Dexamethasone (IFN-dex) as Maintenance Treatment after ThaDD Induction for Multiple Myeloma (MM): First Analysis of a Prospective Randomized Study.

Massimo Offidani, MD, Laura Corvatta, MD, Claudia Polloni, MD, Maria-Novella Piersantelli, MD, Piero Galieni, MD, Giuseppe Visani, MD, Francesco Alesiani, MD, Massimo Catarini, MD, Marino Brunori, MD, Maurizio Burattini, MD, Riccardo Centurioni, MD, Mario Ferranti, MD, Luciano Giuliodori, MD, Marco Candela, MD, Monica Marconi, MD, Pietro Leoni, PhD
Journal: Blood
Blood (2006) 108 (11): 3566.
https://doi.org/10.1182/blood.V108.11.3566.3566
Published: 2006
Journal Articles

Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma

Clinical Trials & Observations
Massimo Offidani, Laura Corvatta, Maria-Novella Piersantelli, Giuseppe Visani, Francesco Alesiani, Marino Brunori, Piero Galieni, Massimo Catarini, Maurizio Burattini, Riccardo Centurioni, Mario Ferranti, Serena Rupoli, Anna Rita Scortechini, Luciano Giuliodori, Marco Candela, Debora Capelli, Mauro Montanari, Attilio Olivieri, Antonella Poloni, Claudia Polloni, Monica Marconi, Pietro Leoni
Journal: Blood
Blood (2006) 108 (7): 2159–2164.
https://doi.org/10.1182/blood-2006-03-013086
Published: 2006
Journal Articles

Thalidomide, Dexamethasone and Pegylated-Liposomal Doxorubicin (ThaDD) for Untreated Multiple Myeloma Patients Aged over 65 Years.

Massimo Offidani, MD, Laura Corvatta, MD, Monica Marconi, MD, Giuseppe Visani, MD, Francesco Alesiani, MD, Marino Brunori, MD, Piero Galieni, MD, Massimo Catarini, MD, Maurizio Burattini, MD, Riccardo Centurioni, MD, Serena Rupoli, MD, Anna Rita Scortechini, MD, Luciano Giuliodori, MD, Marco Candela, MD, Debora Capelli, MD, Mauro Montanari, MD, Attilio Olivieri, Ph. D., Maria-Novella Piersantelli, MD, Pietro Leoni, Ph. D.
Journal: Blood
Blood (2005) 106 (11): 2558.
https://doi.org/10.1182/blood.V106.11.2558.2558
Published: 2005